iBio, Inc Common Stock
Price & Volume
Stats
See more52W Range | $0.63-$6.89 |
Market Cap | $9.2M |
Shares Short | 925,508 |
Financials
See moreRevenue (12 Mos) | $375,000 |
Revenue Growth (YoY) | -87.6% |
Gross Profit (12 Mos) | $375,000 |
Diluted EPS | $1.30 |
News
See moreYahoo Finance • 5 days ago
iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio
Yahoo Finance • 20 days ago
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
Yahoo Finance • 26 days ago
iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025
About
CEO | Dr. Martin B. Brenner D.V.M., Ph.D. |
Address | 11750 Sorrento Valley Road, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
